... to in the content or advertisements. Parkinson’s disease Treatment Bromocriptine Dopamine agonist Neuroprotective effect ...

...-parkinsonian drugs, including levodopa, dopamine agonists, monoamine oxidase inhibitors, anticholinergics, and amantadine HC1 utilizing the smallest effective dose for each drug. The treatment of Parkinson’s disease seems to be moving slowly from mere symptomatic therapy to the one which is aiming...

... to in the content or advertisements. Parkinson’s disease Levodopa Bromocriptine Dopamine agonist ...

...Johannes Schwarz; Klaus Scheidtmann; Claudia Trenkwalder The combination of levodopa and a dopamine agonist in the treatment of patients with Parkinson’s disease often reduces the severity of motor fluctuations. In patients with very severe motor fluctuations, monotherapy with continuous...

..., instructions or products referred to in the content or advertisements. Bromocryptine Parkinson’s disease Levodopa failure Dopamine agonist Eur. Neurol. 1 7: 92-99 (1978) Bromocryptine in Levodopa Response-Losing Parkinsonism A Double Blind Study Ernst N.H. Jansen Department of Neurology, Academic...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Dopamine agonist Bromocriptine Monotherapy Early introduction Long-term treatment Adverse reactions Wearing-off phenomenon Dyskinesia ...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Dopamine metabolism Dopamine agonist...

... parkinsonian drugs, including levodopa. In the third study, cabergoline was switched from another dopamine agonist. All studies proved this drug’s effectiveness in treating such motor symptoms as akinesia, dyskinesia, and nocturnal akinesia. Quality of life and disability in activities of daily living...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Actigraphy Akinesia Parkinson’s disease Limb motor activity Cabergoline Dopamine...